Mima, A., & Horii, Y. (2024). Tirzepatide Reduces Fat Mass and Provides Good Glycaemic Control in Type 2 Diabetes Patients Undergoing Haemodialysis: A Single‐Centre Retrospective Study. Wiley. https://doi.org/10.1002/edm2.489
Citazione stile Chigago Style (17a edizione)Mima, Akira, e Yasuhiro Horii. Tirzepatide Reduces Fat Mass and Provides Good Glycaemic Control in Type 2 Diabetes Patients Undergoing Haemodialysis: A Single‐Centre Retrospective Study. Wiley, 2024. https://doi.org/10.1002/edm2.489.
Citatione MLA (9a ed.)Mima, Akira, e Yasuhiro Horii. Tirzepatide Reduces Fat Mass and Provides Good Glycaemic Control in Type 2 Diabetes Patients Undergoing Haemodialysis: A Single‐Centre Retrospective Study. Wiley, 2024. https://doi.org/10.1002/edm2.489.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.